光生物调节疗法对癌症患者急性放射性皮炎的影响:真实世界证据的系统综述与Meta分析
本系统综述与Meta分析纳入8项研究(5项随机对照试验和3项非随机对照试验),评估光生物调节疗法(PBMT)对癌症患者急性放射性皮炎(ARD)的效果。结果显示,与对照组相比,PBMT组2级和3级ARD发生率显著降低(风险差=-0.36,95%CI=-0.53至-0.19,I²=85%,P<0.00001),在乳腺癌和头颈癌亚组以及预防和治疗亚组中均有显著效果。但纳入研究存在高度异质性,结果需谨慎解读。
要点
- PBMT组2级和3级ARD发生率显著低于对照组(风险差=-0.36,95%CI=-0.53至-0.19)。
- 亚组分析显示PBMT对乳腺癌和头颈癌患者均有显著效果。
- 预防和治疗亚组中PBMT均显著降低2级和3级ARD发生率。
核心结论
- PBMT可能对乳腺癌和头颈癌患者高级别ARD的预防和治疗有益。
- 由于纳入研究存在高度异质性,结果必须谨慎解读。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase、Cochrane Library和CINAHL从建库至2024年7月的文献。
- 纳入8项研究(5项随机对照试验和3项非随机对照试验),评估PBMT对癌症患者ARD的效果。
- 采用随机效应模型进行Meta分析和敏感性分析,并按癌症类型和PBMT目标(预防或治疗ARD)进行亚组分析,按不同ARD分级分层。
主要发现
- 与对照组相比,PBMT组2级和3级ARD发生率显著降低(风险差=-0.36,95%CI=-0.53至-0.19,I²=85%,P<0.00001)。
- 亚组分析显示,与对照组相比,PBMT对乳腺癌和头颈癌均有显著效果。
- 在预防和治疗亚组中,PBMT均显著降低2级和3级ARD发生率。
关键数值与推荐
- PBMT组 vs 对照组:2级和3级ARD发生率风险差=-0.36(95%CI=-0.53至-0.19,I²=85%,P<0.00001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 纳入本Meta分析的研究存在高度异质性(I²=85%)。
- 结果必须谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To examine the effectiveness of photobiomodulation therapy (PBMT) for acute radiation dermatitis (ARD) in patients with cancer. MATERIALS AND METHODS: PubMed, Embase, Cochrane Library, and CINAHL were searched for articles published between database inception until July 2024. Randomized controlled trials (RCTs) and non-RCTs examining the effects of PBMT against ARD in patients with cancer were included for analysis. A random-effects model was used to conduct meta-analyses and sensitivity analyses. Subgroup analyses were conducted for cancer types and PBMT goals (prevention or treatment of ARD) with stratification for different grades of ARD. RESULTS: Eight studies (five RCTs and three non-RCTs) were included in this meta-analysis. Compared with the control group, the PBMT group exhibited significantly lower ARD incidence at grades 2 and 3 (risk difference = - 0.36, 95 % confidence interval = - 0.53 to - 0.19, I2 = 85 %, P = < 0.00001). Subgroup analyses revealed that, compared with the control group, PBMT had a significant effect on both breast cancer and head and neck cancer. In addition, PBMT significantly reduced grades 2 and 3 ARD incidence in the PBMT group for both prevention and treatment subgroups. CONCLUSION: PBMT may have beneficial effects on the prevention and treatment of higher-grade ARD in patients with breast cancer and head and neck cancer. Nevertheless, the studies included in this meta-analysis exhibited high heterogeneity. Therefore, the results must be interpreted with caution.
引用
- Lin YT, Tung KM, Chiou JF, et al. Effects of photobiomodulation therapy for acute radiation dermatitis in patients with cancer: A systematic review and meta‑analysis of real-world evidence. Radiother Oncol. 2024. PMID: 39426526. doi:10.1016/j.radonc.2024.110589
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。